ESR1 and neoplasm: We also investigate if addition of seven more clinical/histopathological variables, including age, tumor size, tumor grade, angioinvasion, estrogen receptor status, progesterone receptor status and lymphocytic infiltrate, to the high-dimensional genomic data on breast cancer patients [6] enhances classification accuracy.